Showing results (11-20 of 686) with videos related to
Sort By:
Pageof 69
Rheumatology and Therapy|October 18, 2016
Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid ArthritisPeter Nash, Johan Vanhoof, Stephen Hall, et al.Rheumatology (Oxford, England)|May 5, 2021
Clinical use of Jak 1 inhibitors for rheumatoid arthritisPeter NashThe Journal of Rheumatology|May 26, 2006
Therapies for axial disease in psoriatic arthritis. A systematic reviewPeter NashCurrent Rheumatology Reports|August 21, 2009
Assessment and treatment of psoriatic spondylitisPeter NashThe Journal of Rheumatology|March 16, 2022
Janus Kinase Inhibitors: Safety in Patients With Psoriatic ArthritisPeter NashRheumatology and Therapy|June 28, 2018
Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis PopulationStephen Hall, Peter Nash, Maureen Rischmueller, et al.Bone|March 23, 2005
Skeletal age deviation assessed by the Tanner-Whitehouse 2 method is associated with bone mass and fracture risk in childrenGraeme Jones, Deqiong MaExpert Review of Clinical Immunology|December 3, 2015
Subcutaneous tocilizumab for the treatment of rheumatoid arthritisEmma Mitchell, Graeme JonesCurrent Rheumatology Reports|November 2, 2018
Clinical Perspective on Pain and Pain Phenotypes in OsteoarthritisFeng Pan, Graeme JonesClinical Medicine Insights. Arthritis and Musculoskeletal Disorders|January 15, 2011
Tocilizumab: a review of its safety and efficacy in rheumatoid arthritisGraeme Jones, Changhai DingPageof 69